NYSE Upgrades: Community Health Systems (NYSE:CYH), Heartland Payment Systems (NYSE:HPY), Medley Capital (NYSE:MCC), Edwards Lifesciences (NYSE:EW)

Community Health Systems (NYSE:CYH) was upgraded by analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm currently has a $55.00 target price on the stock. Oppenheimer’s price target would suggest a potential upside of 55.50% from the stock’s previous close. Community Health Systems (NYSE:CYH) shares after opening at $37.00 moved to $37.00 on last trade day and at the end of the day closed at $36.15. Company price to sales ratio in past twelve months was calculated as 0.32 and price to cash ratio as 11.16. Community Health Systems (NYSE:CYH) showed a negative weekly performance of -2.40%.

Heartland Payment Systems (NYSE:HPY) was upgraded by analysts at Stifel Nicolaus from a sell rating to a hold rating. Heartland Payment Systems, Inc. (NYSE:HPY) shares advanced 6.38% in last trading session and ended the day on $39.88. HPY return on equity ratio is recorded as 41.30% and its return on assets is 11.40%. Heartland Payment Systems, Inc. (NYSE:HPY) yearly performance is 30.41%.

Medley Capital Corp (NYSE:MCC) was upgraded by equities researchers at Gilford Securities from a “neutral” rating to a “buy” rating in a research report issued on Monday, AnalystRatings.NET reports. The firm currently has a $15.00 price objective on the stock. Gilford Securities’ target price points to a potential upside of 14.16% from the company’s current price. Medley Capital Corp (NYSE:MCC) shares moved up 0.99% in last trading session and was closed at $13.27, while trading in range of $13.18 – $13.36. Medley Capital Corp (NYSE:MCC) year to date (YTD) performance is -1.63%.

Edwards Lifesciences Corp (NYSE:EW) was upgraded by equities researchers at Wells Fargo & Co. from a “neutral” rating to a “buy” rating in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm currently has a $90.00 target price on the stock, up from their previous target price of $82.97. Wells Fargo & Co.’s price objective would indicate a potential upside of 23.34% from the company’s current price. Edwards Lifesciences Corp (NYSE:EW) weekly performance is 9.91%. On last trading day company shares ended up $81.00. Edwards Lifesciences Corp (NYSE:EW) distance from 50-day simple moving average (SMA50) is 14.69%. Analysts mean target price for the company is $73.80.